Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.
about
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasisDetection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida speciesNosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.The economic impact of rapid Candida species identification by T2Candida among high-risk patients.Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.T2 Magnetic Resonance for Fungal Diagnosis.Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole.In vitro inhibitory activities of magnolol against Candida spp.T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system.Curcumin-mediated anti-microbial photodynamic therapy against Candida dubliniensis biofilms.Changes in the epidemiological landscape of invasive candidiasis.Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers.Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.The Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after the Initiation of Antifungal Therapy: The Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) trial.Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey.Relative abundance of Candida albicans and Candida glabrata in in vitro co-culture biofilms impacts biofilm structure and formation.[Acute pancreatitis: guideline-based diagnosis and treatment].Microsatellite genotyping of clinical Candida parapsilosis isolates.Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical LaboratoriesPathogenesis of the Candida parapsilosis Complex in the Model Host Caenorhabditis elegans
P2860
Q35076974-BDDA917A-A0BC-4BBD-AD20-0A683EA8D7CCQ35688413-830E99E5-0B0C-4E69-A854-EA469248901AQ36930128-111DEDC0-0518-4CA7-BB0B-16A9FBD5B57BQ37192581-780090E5-FC24-4B0D-8CC1-1A57FA71C540Q37580801-7D57687B-E757-4A6F-B735-C69C4E012786Q37612980-4838D5F6-CCC0-4FDA-8A38-11C979C450FAQ38567197-EE787532-D1FD-4275-BCD6-F99A117E93F5Q38589279-F6A39AA7-0377-4D12-94ED-55D0E9EADCA5Q38711698-53BA73E7-CDB5-47BB-B462-AD85F5F5F483Q39020917-FD09DA1A-B68D-463E-919C-8D453FCB1F08Q40118569-4D0E11C6-6E20-45B4-A891-C981F1458BFEQ40202924-DBAA5418-2C79-479C-A407-B25AD070170BQ40454814-915317B7-8DA7-4FD3-932C-D2EC99E803DDQ40640348-4E040A28-0D4B-4BA9-956A-8F97058A708DQ41194345-FC51FC11-11E6-4062-B9C1-60F89012879CQ41355300-743CF62D-DD93-44E7-9D6D-B9DE89FDC59EQ41546170-E9A50673-CE23-4E79-8E69-EB9DBD5A61D6Q41633108-81279F70-64A7-4492-904F-A4A8CCBDAEF6Q47603035-BE6EF8BA-E565-4F09-8521-3DFF3BEE34BCQ47749844-D3776BD9-CDBE-445B-8C90-2228BE8EF941Q48523172-404C07D2-BEC9-4AB2-BE1F-B321BE4397D3Q49425859-1BFFE119-6C99-483A-960B-1AF216169A35Q49789481-C1CE188A-D3FA-4361-B336-D17653172719Q50041728-9933F989-B781-47CB-9A75-A2C4B0520167Q50050075-A7D2A7FA-BB5E-454A-8524-3675F3A42A22Q50181614-5B47368F-89B0-40FA-92D0-34FC4DB32B0FQ55008952-B1CA7DA5-3DFF-4BCD-B707-31D897DFB76FQ57745988-827CE710-7A46-401A-B604-4018631F6C05Q58795146-BCE33021-FC91-434A-8187-3C3998BF4305
P2860
Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@ast
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@en
type
label
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@ast
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@en
prefLabel
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@ast
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@en
P2860
P356
P1433
P1476
Regional data analysis of Cand ...... er a 6-year period, 2006-2011.
@en
P2093
Ronald N Jones
P2860
P304
P356
10.1111/MYC.12206
P577
2014-05-26T00:00:00Z